 Todos Medical Ltd. OTCQB:TOMDF said it has signed an amendment to its agreement with its 3CL protease biology theranostics partner NLC Pharma Ltd, with the latter assigning ownership of all relevant intellectual property IP to majority-owned joint venture 3CL Pharma Ltd. 